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Abstract 
Review on PCSK6, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: PACE4, SPC4 




This gene can be found on chromosome 15 at 
location: 101844134-102029873. 
Transcription 
The DNA sequence contains 23 exons and the 




PCSK6 is a member of the family of subtilisin-like 
proprotein convertases (PCs) that process precursor  
proteins at their paired basic amino acid processing 
sites (RXR).  
This protease undergoes an initial autocatalytic 
processing event in the endoplasmic reticulum (ER) 
to generate a heterodimer which exits the ER and 
sorts to the trans-Golgi network (TGN). In the TGN 
a second autocatalytic cleavage takes place in order 
to release an active PCSK6. 
Expression 
PCSK6 is expressed in many tissues and encoded by 
different alternatively spliced mRNAs: the 
PACE4A-I form is secreted and expressed in heart, 
brain, placenta, lung, skeletal muscle, kidney, 
pancreas, but at comparatively higher levels in the 
liver. Isoform PACE4A-II is secreted and at least 
expressed in placenta. Isoform PACE4B is secreted 
and was only found in the embryonic kidney cell line 
from which it was isolated. Isoforms PACE4C and 
PACE4D are located in ER (not secreted, remain 
probably inactive unprocessed form in endoplasmic 
reticulum) and expressed in placenta too. Isoforms 
PACE4E-I and PACE4E-II are probably retained 
intracellularly through a hydrophobic cluster in their 
C-terminus, and expressed in cerebellum (E-I and -
II), placenta and pituitary (only E-I). The PACE4CS 
was also found to probably lack enzymatic activity. 












PCSK6 is activated predominantly at the cell surface 
and able to process its substrates within the 
extracellular matrix and cell surface. 
Function 
PCSK6 induce protein precursors cleavage at the R-
X-(K/R)-R motif to release mature proteins. PCSK6 
substrates include enzymes (ADAMTS-4 and 
ADAMTS-5), HIV accessory protein Vpr, NODAL, 
TGF-beta related proteins, proalbumin and von 
Willebrand factor. This protein is thought to play a 
role in tumor progression and left-right patterning. 
Homology 
The PCSK6 catalytic domain has a high percentage 
of homology with those of the other PCs: 42% 
between PCSK6 and Furin. 
Implicated in 
Breast cancer 
Higher expression of PCSK6 has been detected in 
human breast cancer. There was a correlation 
between the amount of PACE4 gene product and 
estrogen receptor content. 
Prostate cancer 
A recent study demonstrated that PSCK6 was highly 
overexpressed in prostate cancer tissues. 
Skin cancer 
Transgenic expression of PACE4 in keratinocytes of 
the epidermal basal layer was more susceptible to 
chemical carcinogenesis, evidenced by increased 
tumor multiplicity, tumor volume, and metastasis. 
Association with degree of 
handedness 
There is a significant association with a VNTR 
polymorphism in PCSK6 and handedness. 
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